Sagimet Biosciences Inc. (SGMT)
(Delayed Data from NSDQ)
$6.92 USD
-0.42 (-5.72%)
Updated Sep 29, 2025 04:00 PM ET
After-Market: $6.90 -0.02 (-0.29%) 6:32 PM ET
2-Buy of 5 2
F Value D Growth D Momentum F VGM
Fundamental Charts
About Return on Equity (TTM)
Sagimet Biosciences Inc.'s return on equity, or ROE, is -39.88% compared to the ROE of the Medical - Biomedical and Genetics industry of -66.95%. While this shows that SGMT has struggled to make solid use of its equity, this metric will vary significantly from industry to industry.
Return on Equity (or ROE) is calculated as income divided by average shareholder equity (past 12 months, including reinvested earnings). The income number is listed on a company's Income Statement. Shareholder Equity (which is the difference between Total Assets and Total Liabilities) can be found on the Balance Sheet.
SGMT 6.92 -0.42(-5.72%)
Will SGMT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for SGMT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SGMT
Here's Why Sagimet Biosciences Inc. (SGMT) is Poised for a Turnaround After Losing 15.8% in 4 Weeks
Sagimet Biosciences Inc. (SGMT) Upgraded to Buy: What Does It Mean for the Stock?
SGMT: What are Zacks experts saying now?
Zacks Private Portfolio Services
After Plunging 28% in 4 Weeks, Here's Why the Trend Might Reverse for Sagimet Biosciences Inc. (SGMT)
What Makes Sagimet Biosciences Inc. (SGMT) a Strong Momentum Stock: Buy Now?
Wall Street Analysts Predict a 437.05% Upside in Sagimet Biosciences Inc. (SGMT): Here's What You Should Know
Other News for SGMT
Stochastic Reached Overbought appears for SGMT after 2.8% move
Technical picture remains unchanged for SGMT after it falls 1.92% on September 26
Crossed Above 20 Day Moving Average appears for SGMT after 8.17% move
SGMT forms 20 Day Moving Average Resistance on September 24
Is SGMT set to rally? MACD Bullish Signal Line Cross shows up after climbing 4.45%